Amended Current Report Filing (8-k/a)
December 27 2019 - 1:55PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported: December 20,
2019
TARGET
GROUP INC.
(Exact name of registrant as specified in
its charter)
Delaware
|
000-55066
|
46-3621499
|
State or other jurisdiction incorporation
|
Commission File Number
|
IRS Employer Identification No.
|
55 Administration Road, Unit 13, Vaughan,
Ontario, Canada L4K 4G9
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (647) 927-4644
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company x
For an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
Emerging Growth Company ¨
Securities registered pursuant to Section 12(b) of the Securities
Exchange Act of 1934:
Title of each class
|
Trading symbol
|
Name of each exchanges on which registered
|
N/A
|
N/A
|
N/A
|
Explanatory Note:
This amended report on Form 8-K
amends the recent business biography of Barry Katzman
|
Section 2-
|
Financial Information
|
|
Item 2.03
|
Creation of a Direct Financial Obligation or an Obligation
under an Off- Balance Sheet Arrangement of a Registrant
|
Effective December
20, 2019 the Company entered into a financing agreement (“Agreement”) with a private individual
(“Lender”) to provide working capital and payables funding to the Company up to the principal
amount of CND$1,000,000.00. The initial tranche advanced to the Company on December 20, 2019 was CND$350,000.00. All funds advanced
under the Agreement will bear interest at the rate of 16% per annum. The maturity date of the funds advanced will be twelve (12)
months from the date of the Agreement.
All funds advanced
will be secured by a security interest in all of the personal property, including without limitation, all intellectual property
of the Company and its subsidiaries. In addition to the security interest in personal property, the Lender will have a first lien
on the leasehold interest on the premises occupied by the Company’s second-tier subsidiary, Canary Rx Inc., located in Simcoe,
Ontario, Canada.
|
Section 5-
|
Corporate Governance and Management
|
|
Item 5.02
|
Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
|
Pursuant to the Agreement
referred to in Item 2.03 of this Report, effective December 20, 2019 Barry Alan Katzman was appointed a director and Co-Chief Executive
Officer of the Company. Most recently, Mr. Katzman was the President and CEO of Tidal Health Solutions, a licensed premium medical
cannabis company based in New Brunswick, Canada specializing in hospital-grade medical cannabis. At the present time, there are
no compensatory plans, contracts or arrangements to which Mr. Katzman is a party.
Signatures
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
TARGET GROUP INC.
|
|
|
|
|
|
Dated: December 27, 2019
|
By:
|
/s/ Rubin Schindermann
|
|
|
|
Co-Chief Executive Officer
|
|
Target (PK) (USOTC:CBDY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Target (PK) (USOTC:CBDY)
Historical Stock Chart
From Sep 2023 to Sep 2024